Circulating desmosine as a biomarker of azithromycin treatment response: a post hoc analysis of the COLUMBUS randomised controlled trial

Circulating desmosine is not reduced by treatment with azithromycin in COPD but elevated desmosine may identify a patient group with a greater treatment response http://ow.ly/vN6N30mhBA1

Detalles Bibliográficos
Autores principales: Chalmers, James D., Djamin, Remco S., Schouten, Marjolijn, Keir, Holly R., Tan, Brendan, Aerts, Joachim G.J.V., Huang, Jeffrey T-J., van der Eerden, Menno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2018
Materias:
Original Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6230815/
https://www.ncbi.nlm.nih.gov/pubmed/30443554
http://dx.doi.org/10.1183/23120541.00136-2018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6230815/
https://www.ncbi.nlm.nih.gov/pubmed/30443554
http://dx.doi.org/10.1183/23120541.00136-2018

Ejemplares similares